TY - JOUR
AU - Barbara Andraka-Christou
AU - Matthew Douglas Evans
AU - Beth Tranen
AU - Natasha S. Mendoza
A1 - 
AD - School of Global Health Management & Informatics, University of Central Florida, Orlando, FL, US Barbara.andraka@ucf.edu; New Hope Behavioral Health Center, Mesa, AZ, US ; Southern Arizona Health Care System, Tucson, AZ, US ; School of Social Work, Watts College of Public Service and Community Solutions, Arizona State University, Phoenix, AZ, US ; Andraka-Christou, Barbara,525 W Livingston Street, Suite 401,Orlando,US,32801,School of Global Health Management & Informatics, University of Central Florida,Barbara.andraka@ucf.edu
BT - Substance Use & Misuse
C5 - Opioids & Substance Use ; Healthcare Policy
CP - 7
DB - APA PsycInfo®
DO - 10.1080/10826084.2023.2196688
IS - 7
JF - Substance Use & Misuse
LA - English
PY - 2023
SN - 1082-6084, 1082-6084
SP - 956
EP - 959+
ST - Legal limitations associated with microdosing buprenorphine
T1 - Legal limitations associated with microdosing buprenorphine
T2 - Substance Use & Misuse
TI - Legal limitations associated with microdosing buprenorphine
U1 - Opioids & Substance Use ; Healthcare Policy
U3 - 10.1080/10826084.2023.2196688
VL - 58
VO - 1082-6084, 1082-6084
Y1 - 2023
ER -